...
首页> 外文期刊>Indian drugs >FORMULATION AND EVALUATION OF SUSTAIN RELEASE CYCLOBENZAPRINE HYDROCHLORIDE PELLETS
【24h】

FORMULATION AND EVALUATION OF SUSTAIN RELEASE CYCLOBENZAPRINE HYDROCHLORIDE PELLETS

机译:维持释放环烷基氨碱盐酸粒粒料的制剂和评价

获取原文
获取原文并翻译 | 示例

摘要

Cyclobenzaprine Hydrochloride is a centrally acting muscle relaxant which is mostly available in the form of tablets and capsules. The present aim of the study was to develop a sustained release formulation of cyclobenzaprine Hydrochloride pellets using powder layering technique. Nine different formulations of pellets were prepared by using different concentrations of Ethyl Cellulose-50, Hypromellose (HPMC), and PEG 6000 of all formulations, F8 formulation was the optimized formulation. The kinetic studies of F8 formulation was best fitted in the First order model as it had the highest value (R~2= 0.981) and it follows non- fickian diffusion. Among all the formulations F8 gave better drug release 85.7% when compared to innovator, F8 was selected as optimized formulation. The optimized formulation was kept for stability studies for 3 months at 40°C /75% RH and 25°C /60% RH and the results indicated that there was no much variation in their physiochemical characteristics and the formulation was found to be stable.
机译:环己酰氨基盐酸盐是一种集中作用肌肉松弛剂,主要是片剂和胶囊的形式。该研究的目前目的是使用粉末层化技术开发环烷基萘碱盐酸盐颗粒的持续释放制剂。通过使用不同浓度的乙基纤维素-50,氰酰胺(HPMC)和所有制剂的PEG 6000来制备九种不同的颗粒制剂,F8制剂是优化的制剂。 F8配方的动力学研究最适合在第一阶模型中装配,因为它具有最高值(R〜2 = 0.981),并且遵循非Fickian的扩散。在与创新者相比,F8的所有制剂F8提供了更好的药物版本85.7%,选择F8作为优化的配方。优化的制剂在40℃/ 75%RH和25℃/ 60%RH下保持稳定性研究3个月,结果表明它们的生理化学特性没有多少变化,并且发现配方是稳定的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号